Sulfuric Acid

Sulfuric Acid

SCHEMBL4245147

CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.O=S(=O)([O-])[O-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 2/20 0.37
PABPC1 P11940 1/20 0.37
HPGD P15428 1/20 0.37
RXFP1 Q9HBX9 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
BLM P54132 1/20 0.37
APAF1 O14727 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
MEN1 O00255 1/20 0.35
HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28980889 1.00 KDM4E (0.37) KDM4EALDH1A1MAPTSMN1; SMN2HTT
Sulfuric Acid SCHEMBL28449062 1.00 KDM4E (0.37) KDM4EALDH1A1MAPTSMN1; SMN2HTT
Sulfuric Acid SCHEMBL316621 0.98 KDM4E (0.37) KDM4EALDH1A1MAPTSMN1; SMN2HTT
Sulfuric Acid SCHEMBL29028943 0.95 ALDH1A1 (0.35) KDM4EALDH1A1MAPTSMN1; SMN2HTT
SCHEMBL193628 0.95 KDM4E (0.37) KDM4EALDH1A1MAPTSMN1; SMN2HTT
SCHEMBL28652452 0.95 KDM4E (0.37) KDM4EALDH1A1MAPTSMN1; SMN2HTT
Sulfuric Acid SCHEMBL582397 0.93 SMN1; SMN2 (0.36) KDM4EALDH1A1MAPTSMN1; SMN2HTT
SCHEMBL28673400 0.93 ALDH1A1 (0.36) KDM4EALDH1A1MAPTSMN1; SMN2HTT
Sulfuric Acid SCHEMBL18091450 0.92 ABCB11 (0.41)
Sulfuric Acid SCHEMBL3687199 0.92 ABCB11 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114883536-A Preparation method of hollow fiber tubular lithium battery anode 上海大学 2022-08-09 CN claimed
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN claimed
CN-110713501-B Preparation method of glucosamine calcium sulfate salt 山东润德生物科技有限公司 2021-04-06 CN claimed
EP-1812382-B1 METHOD FOR PRODUCING POLYISOCYANATES BASF SE (DE) 2013-01-23 EP claimed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US claimed
EP-1663921-B1 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AG (DE) 2007-05-02 EP claimed
US-20070055084-A1 Method for producing haloalkanes from alcohols BASF AKTIENGESELLSCHAFT (DE) 2007-03-08 US claimed
CN-119039071-A Method and apparatus for preparing water-soluble compound fertilizer 中化化肥有限公司临沂农业研发中心 2024-11-29 CN disclosed
CN-117440991-A Polysiloxane composition 默克专利有限公司 2024-01-23 CN disclosed
CN-111836849-B Process for producing fibers, films and moldings of polybenzazole polymer (P) 巴斯夫欧洲公司 2023-04-07 CN disclosed
CN-111435705-B Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2023-04-07 CN disclosed
CN-114981281-A Method for producing oligonucleotide compound 日本新药株式会社 2022-08-30 CN disclosed
EP-3512905-B1 METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) BASF SE (DE) 2022-08-24 EP disclosed
CN-101680885-B Detection of Analytes in Hemolyzed Whole Blood Samples 霍夫曼-拉罗奇有限公司 2017-03-15 CN disclosed
US-9147919-B2 Methods of producing sulfate salts of cations from heteroatomic compounds and dialkyl sulfates and uses thereof FLUIDIC, INC. (US) 2015-09-29 US disclosed
US-8252943-B2 Method for the production of compounds with quaternary sp2-hybridised nitrogen atoms BASF SE (DE) 2012-08-28 US disclosed
US-7897806-B2 Reacting primary amines with phosgene in ionic liquid as solvent BASF AKTIENGESELLSCHAFT (DE) 2011-03-01 US disclosed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US disclosed
US-20070142642-A1 Method for the production of compounds with quaternary sp2-hybridised nitrogen atoms BASF AKTIENGESELLSCHAFT (DE) 2007-06-21 US disclosed
US-20070055084-A1 Method for producing haloalkanes from alcohols BASF AKTIENGESELLSCHAFT (DE) 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES PGLS, INMT, PNMT KDM4E 3386/4885ALDH1A1 4028/4885MAPT 1739/4885
US-20070142642-A1 Method for the production of compounds with quaternary sp2-hybridised nitrogen atoms NPM1, RANBP2, NCLN KDM4E 3903/4885ALDH1A1 4709/4885MAPT 3137/4885
US-20070055084-A1 Method for producing haloalkanes from alcohols ADH1C, HDHD5, ADH5 KDM4E 2710/4885ALDH1A1 493/4885MAPT 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.